A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain (LIMPP)
Continuous Post-operative Lidocaine Infusion Following Major Reconstructive Spine Surgery in the Elderly to Minimize Delirium and Opiate Use: A Randomized Control Trial
Sponsor: University of California, San Francisco
A PHASE3 clinical study on Postoperative Delirium and Postoperative Pain, this trial is actively recruiting participants. The trial is conducted by University of California, San Francisco and has accumulated 7 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Jun 2025 — Present [monthly]
Recruiting PHASE3
Status: Unknown → Recruiting
-
Oct 2024 — Jun 2025 [monthly]
Unknown PHASE3
Status: Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Apr 2022 — Jul 2024 [monthly]
Recruiting PHASE3
▶ Show 2 earlier versions
-
Oct 2021 — Apr 2022 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .